ad

Saregama India Q1 Results FY27: Uniresearch Prediction and Analysis

Saregama India Q1 Results FY27: Uniresearch projects Revenue Rs 209 Cr | PAT Rs 37 Cr (Uniresearch trailing analysis). Q4 FY26: Rev Rs 287 Cr | PAT Rs 74 Cr.


25 Jun 20263:08 pm

Saregama India Q1 Results FY27: Uniresearch Prediction and Analysis

Saregama India Q1 Results FY27 outlook from Uniresearch is anchored on verified Q4 FY26 actuals and Uniresearch trailing analysis. Uniresearch projects Saregama India Q1 FY27 Revenue Rs 209 Cr (+1.0% YoY) and PAT Rs 37 Cr (+0.0% YoY). Prepared by Kunal Singla.

Click Here – Get Free Investment Predictions

Saregama India Q1 Results FY27 – Uniresearch Prediction

Metric Q1 FY26 Actual Q1 FY27 Uniresearch Prediction YoY Change Source
Saregama India Revenue (Rs Cr) 207 209 +1.0% Uniresearch | Uniresearch trailing analysis
PAT (Rs Cr) 37 37 +0.0% Uniresearch | Uniresearch trailing analysis
Avg Analyst Target See screener 12-month view Uniresearch trailing analysis

Saregama India Q4 FY26 Performance

Metric Q4 FY26 Actual vs Q1 FY26 Source
Revenue (Rs Cr) 287 +38.6% Screener consolidated
PAT (Rs Cr) 74 +100.0% Screener consolidated

Analyst Views and Growth Outlook

The Uniresearch trailing analysis projects Saregama India FY27 revenue at +1.0% and profit at +0.0% YoY. Uniresearch applied these growth rates to Q1 FY26 actuals to derive the Q1 FY27 prediction. Q4 FY26 actuals showed Saregama India delivering revenue of Rs 287 Cr and PAT of Rs 74 Cr.

Key Watchpoints

Revenue Delivery

Key question: can Saregama India reach Rs 209 Cr in Q1 FY27 revenue, representing +1.0% YoY growth over the Q1 FY26 base of Rs 207 Cr.

PAT vs Growth Target

Profit performance of Rs 37 Cr (+0.0%) vs the Q1 FY26 base of Rs 37 Cr is the profitability watchpoint for Saregama India in Q1 FY27.

Risks

Revenue Shortfall

Revenue below the +1.0% consensus would indicate sector headwinds or execution delays for Saregama India.

Margin Pressure

Cost increases or margin compression could challenge the +0.0% PAT growth projection for Saregama India in Q1 FY27.

Conclusion

The Saregama India Q1 FY27 Uniresearch projection of Revenue Rs 209 Cr and PAT Rs 37 Cr is derived from the Uniresearch trailing analysis. Investors should watch Q4 FY26 actuals as the base, and track Saregama India live on the Univest Screener.

Track Saregama India Live on the Univest Screener

Download the Univest iOS App or Univest Android App for live FY27 alerts.

Disclaimer: Revenue and PAT actuals are sourced from consolidated quarterly financial data. Q1 Results FY27 Uniresearch predictions are derived by applying analyst consensus growth rates to verified Q1 FY26 actuals. These are projections, not guaranteed outcomes. Investments in securities are subject to market risk. For educational purposes only. SEBI RA INH000013776.

FAQs on Saregama India Q1 Results FY27

What is Uniresearch’s PAT prediction for Saregama India Q1 Results FY27?

Ans. Uniresearch projects Saregama India Q1 FY27 PAT at Rs 37 Cr (+0.0% vs Q1 FY26 base Rs 37 Cr).

What is the Revenue forecast for Saregama India Q1 Results FY27?

Ans. Saregama India Q1 FY27 Revenue is projected at Rs 209 Cr (+1.0% consensus).

What were Saregama India Q4 FY26 actuals for Saregama India Q1 Results FY27?

Ans. Q4 FY26 Revenue Rs 287 Cr and PAT Rs 74 Cr.

How many analysts cover Saregama India Q1 Results FY27?

Ans. The prediction uses Uniresearch trailing analysis, avg target Rs 0.

What consensus applies to Saregama India Q1 Results FY27?

Ans. Revenue +1.0% and profit +0.0% (Uniresearch trailing analysis).

What are the main risks to Saregama India Q1 Results FY27?

Ans. Revenue missing +1.0% consensus and PAT pressure vs +0.0% growth target.

What is the Q1 FY26 base for Saregama India Q1 Results FY27?

Ans. Q1 FY26 Revenue Rs 207 Cr and PAT Rs 37 Cr.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
Google for Startups Accelerator 2024
Trusted by 70 lakh+ Indians
Awarded No. 1 by Economic times

GET THE APP

Join 1Cr+ users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Univest

100% Safe and Secure Platform

Univest encrypts all data and transactions to ensure a completely secure experience for our members.

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down